Optimization of the Antitumor Activity of Sequence-specific Pyrrolobenzodiazepine Derivatives Based on their Affinity for ABC Transporters
Journal Title: The AAPS Journal - Year 2010, Vol 12, Issue 4
Abstract
The online version of this article (doi:10.1208/s12248-010-9225-x) contains supplementary material, which is available to authorized users.
Authors and Affiliations
Maciej Kaliszczak, Dyeison Antonow, Katan I. Patel, Philip Howard, Duncan I. Jodrell, David E. Thurston, Sylvie M. Guichard
Keywords
Related Articles
- EP ID EP681425
- DOI 10.1208/s12248-010-9225-x
- Views 47
- Downloads 0
Pharmacokinetic and pharmacodynamic effects of high-dose monoclonal antibody therapy in a rat model of immune thrombocytopenia
Intravenous administration of pooled, polyvalent human immunoglobulin (IVIG) has been used for over 20 years as a therapy for immune thrombocytopenia (ITP). IVIG is available in limited quantities, and clinical preparati...
Performance of Methods for Handling Missing Categorical Covariate Data in Population Pharmacokinetic Analyses
The online version of this article (doi:10.1208/s12248-012-9373-2) contains supplementary material, which is available to authorized users.
How Promiscuous Are Pharmaceutically Relevant Compounds? A Data-Driven Assessment
The online version of this article (doi:10.1208/s12248-012-9421-y) contains supplementary material, which is available to authorized users.
Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats
Biochanin A(BCA) is a dietary isoflavone present in legumes, most notably red clover, and in many herbal dietary supplements. BCA has been reported to have chemopreventive properties and is metabolized to the isoflavone...
Practical Anticipation of Human Efficacious Doses and Pharmacokinetics Using In Vitro and Preclinical In Vivo Data
Accurate predictions of human pharmacokinetic and pharmacodynamic (PK/PD) profiles are critical in early drug development, as safe, efficacious, and “developable” dosing regimens of promising compounds ha...